|
KMID : 1040620190250020199
|
|
Clinical and Molecular Hepatology
2019 Volume.25 No. 2 p.199 ~ p.209
|
|
|
Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
|
|
Sharma Manoj Kumar
Kainth Sumeet
Kumar Sachin
Bhardwaj Ankit
Agarwal Hemant Kumar
Maiwall Rakhi
Jamwal Kapil Dev
Shasthry Saggere Muralikrishna
Jindal Ankur
Choudhary Ashok
Anand Lovkesh
Dhamija Rajender Mal
Kumar Guresh
Sharma Barjesh Chander
Sarin Shiv Kumar
|
|
|
Abstract
|
|
|
Background/Aims: The aim of this study was to study the efficacy and safety of zolpidem for sleep disturbances in patients with cirrhosis.
Methods: Fifty-two Child-Turcotte-Pugh (CTP) class A or B cirrhotics with Pittsburgh Sleep Quality Index >5 were randomized to either zolpidem 5 mg daily (n=26) or placebo (n=26) for 4 weeks.
Results: The therapy of 4 weeks was completed by 23 patients receiving zolpidem (3 stopped treatment due to excessive daytime drowsiness) and 24 receiving placebo (2 refused to continue the study). In the zolpidem group, after 4 weeks of therapy, there was significant increase in total sleep time (TST) and sleep efficiency compared to baseline and improvement in polysomnographic parameters of sleep initiation and maintenance (i.e., decrease in sleep latency time, decrease in wake time, and decreases in number of arousals and periodic limbs movements per hour of sleep), without any significant change in sleep architecture.
Conclusions: Four weeks of 5 mg daily zolpidem in CTP class A or B cirrhosis patients with insomnia led to significant increases in TST and sleep efficiency and improvement in polysomnographic parameters of sleep initiation and maintenance without any significant change in sleep architecture.
|
|
|
KEYWORD
|
|
|
Cirrhosis, Sleep, Zolpidem, Insomnia
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|